Capstone Therapeutics Corp. (CAPS)
(Delayed Data from NSDQ)
$1.32 USD
-0.04 (-2.94%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $1.31 -0.01 (-0.76%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Capstone Therapeutics Corp.'s dividend yield currently sits at 0%, which is in-line with the Building Products - Miscellaneous industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CAPS 1.32 -0.04(-2.94%)
Will CAPS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAPS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAPS
Capstone Holding (CAPS) Launches Corporate Development Team to Boost Acquisitions
Capstone announces formation of Corporate Development team
Capstone Holding Corp. Accelerates Acquisition Strategy with Launch of Dedicated Corporate ...
Capstone Holding Corp. Accelerates Acquisition Strategy with Launch of Dedicated Corporate Development Team
Capstone Therapeutics (CAPS) Plans to Sell Over 4 Million Common Shares